Oskar Slotboom

Examiner
DISC Type : cs

Managing Partner at BioGeneration Ventures

Naarden, North Holland, Netherlands

Overview

Oskar Slotboom is a Managing Partner at BioGeneration Ventures (BGV), a venture capital firm specializing in early-stage European life sciences companies. His expertise in commercial strategy and business development is built on previous roles as CCO of Avantium and various leadership positions at Crucell, which became part of Johnson & Johnson.

He holds an MBA from INSEAD and a degree in chemical engineering from the University of Twente. Oskar serves on the boards of several portfolio companies, actively guiding their growth and strategy.

He played a key role in one of Europes most successful biotech startups, Acerta Pharma, a BGV portfolio company acquired by AstraZeneca for up to $7 billion.

Personality Overview

Late Adopter

Status Quo Seeker

Process Oriented

They do not like taking risks at all and go for proven options in the end.  They are thorough and always follow a systematic approach. Being observant comes to them naturally.

Topics They Care About

European Biotech Investing
He believes the fundamentals for European biotech are very strong, citing high levels of innovation and more reasonable valuations compared to the U. S. market.
Early-Stage Ventures
His firm, BGV, focuses on seed investments and acts as a lead investor for innovative companies, aiming to get involved early to shape their development.
Pharma M&A Strategy
His experience includes the successful exit of Acerta Pharma to AstraZeneca, giving him deep insight into structuring large-scale pharmaceutical acquisitions.

Media Appearances

Oskar Slotboom – Managing Partner, BioGeneration Ventures (Team Profile). Featured in BioGeneration Ventures

See Now

Work History

7-2016
Managing Partner at BioGeneration Ventures
9-2014 - 7-2016
Chief Commercial Officer at Avantium
1-2012 - 8-2014
BU Head, Vaccines and Infectious Diseases at Crucell China / Xian Janssen (part of Johnson&Johnson)
11-2008 - 1-2012
Business Manager Paediatric at Crucell
8-2006 - 11-2008
Director Business Development at Crucell

Education

9-2001 - 7-2002
MBA from INSEAD
1993 - 1998
MSE from University of Twente

More Information

Social Presence :

Prographics :

Exp : 23 Location : Naarden, North Holland, Netherlands Job Level : Senior Designation : Managing Partner at BioGeneration Ventures
URL has been copied!

Insights For Selling To Oskar

During A Call Or A Meeting

DO's

  • Be firm in your communication and stay in control
  • Expect them to be slow and cautious, encourage them to ask more questions
  • Spend time addressing concerns around risk and change, they will have them even if they don't express them

DONT's

  • Don't use phrases like 'do not worry', 'i promise' etc.
  • Don't push them too hard to make fast decisions, give them time
  • Avoid getting into storytelling mode, especially when they ask specific questions

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Oskar is

  • Low-risk, adoption by others are very important to them, followed by confidence in ROI.
  • Will you ever get a clear answer from Oskar

  • Often, they don't say no, or keep going about it in circles.

Insights For Deal Planning

    How fast (or slow) will Oskar move?

  • They do not like to rush and therefore can be quite slow in their decision-making.
  • Can Oskar take some risk or not?

  • They have little risk-appetite and prefer to take measured decisions.

You And Oskar

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.